Cargando…
Next Steps Toward AMH as a Robust Biomarker for Assessing Ovarian Aging in Individual Women
Autores principales: | Fauser, Bart C J M, Nelson, Scott M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450215/ https://www.ncbi.nlm.nih.gov/pubmed/32315387 http://dx.doi.org/10.1210/clinem/dgaa220 |
Ejemplares similares
-
Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome
por: Moolhuijsen, Loes M E, et al.
Publicado: (2022) -
The Use of AMH to Assess Ovarian Toxicity in Adolescents and Young Adults After Cancer Treatment
por: Anderson, Richard A, et al.
Publicado: (2020) -
Bridging worldviews: Toward a common model of leadership across the health professions
por: Garman, Andrew N., et al.
Publicado: (2020) -
Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome
por: Fraser, Graeme L, et al.
Publicado: (2021) -
Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)